Evidence map›Paper›PMID 26175941›Full record

ArticleAmerican journal of cancer research2015

Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation.

Qing-Cai Meng, Hong-Cheng Wang, Zi-Liang Song, Ze-Zhi Shan, Zhou Yuan, Qi Zheng, Xin-Yu Huang

Open access · greenAbstract read
In one paragraph

Article in American journal of cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Qing-Cai MengDepartment of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University 600 Yi-Shan Road, Shanghai 200233, China.
Hong-Cheng WangDepartment of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University 600 Yi-Shan Road, Shanghai 200233, China.
Zi-Liang SongDepartment of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University 600 Yi-Shan Road, Shanghai 200233, China.
Ze-Zhi ShanDepartment of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University 600 Yi-Shan Road, Shanghai 200233, China.
Zhou YuanDepartment of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University 600 Yi-Shan Road, Shanghai 200233, China.
Qi ZhengDepartment of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University 600 Yi-Shan Road, Shanghai 200233, China.
Xin-Yu HuangDepartment of General Surgery, Sixth People's Hospital Affiliated Shanghai Jiao Tong University 600 Yi-Shan Road, Shanghai 200233, China.
Shanghai Sixth People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsNDC80/Hec1, one of four proteins of the outer kinetochore NDC80 complex, is involved in the tumorigenesis of a variety of cancers. In this study, we focused on that NDC80 is overexpressed in human pancreatic cancer and investigates the role of NDC80-knockdown in pancreatic cancer cells proliferation. MATERIALS AND

methodsWe determined the expression levels of NDC80 on both mRNA and protein levels in fresh pancreatic cancer tissues and cells by quantitative real-time polymerase chain reaction and immunoblotting, respectively. Furthermore, protein level of NDC80 was identified using immunochemistry in paraffin-embedded tumor specimen, with correlation between NDC80 expression and various clinicopathological parameters evaluated. The role of NDC80 in pancreatic cancer cells (Panc-1) growth was investigated by lentivirus-mediated silencing of NDC80. The effect of NDC80 deletion on cell proliferation was analyzed by MTT assay and clone formation assay, while cell cycle distributions and apoptosis were analyzed by flow cytometry.

resultsThe mRNA and protein of NDC80 were overexpressed in pancreatic cancer tissues and cells. The statistical analysis based on immunohistochemical evaluation suggested that NDC80 overexpression was signifi cantly associated with clinicopathological parameters including pathological T staging and N staging, which may be served as an predictor for poor outcomes. The silencing of NDC80 in Panc-1 cells could suppress cell proliferation and colony formation. Furthermore, the NDC80-siRNA infected Panc-1 cells lead to cell cycle arrest at G2/M phase and induction of apoptosis.

conclusionThese results demonstrated that NDC80 plays an essential role in the tumorigenesis of pancreatic cancer, and might serve as potential prognostic and therapeutic target for treatment of pancreatic cancer.

Indexed as

apoptosisNDC80pancreatic cancerproliferation

Identifiers

PMID26175941
PMCPMC4497439
OpenAlexW2438230054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.